Christopher Horan
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Christopher Horan is currently Chief Technical Operations Officer at Artiva Biotherapeutics, Inc. since 2021.
Formerly, Mr. Horan was Vice President-North American Supply Chain at Genentech, Inc. from 2007 to 2011, Senior VP-Product & Global Supply Chain Management at Roche Pharmaceuticals, Inc. from 2013 to 2018, and Chief Technical Operations Officer at Dermira, Inc. from 2018 to 2020.
Mr. Horan completed undergraduate education at Stevens Institute of Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 19.05.2026 | 293’450 ( 0.6% ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ARTIVA BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
| DERMIRA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2020 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01.03.2018 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.07.2011 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Stevens Institute of Technology
Stevens Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermira, Inc.
Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops natural killer cell-based therapies for patients suffering from autoimmune diseases and cancers | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen